Global Longlife Hospital and R
Global Longlife Hospital and R Fundamental Analysis
Global Longlife Hospital and R (GLHRL.BO) shows weak financial fundamentals with a PE ratio of 86.37, profit margin of 34.42%, and ROE of 0.76%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 76.0/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze GLHRL.BO's fundamental strength across five key dimensions:
Efficiency Score
WeakGLHRL.BO struggles to generate sufficient returns from assets.
Valuation Score
ModerateGLHRL.BO shows balanced valuation metrics.
Growth Score
WeakGLHRL.BO faces weak or negative growth trends.
Financial Health Score
ExcellentGLHRL.BO maintains a strong and stable balance sheet.
Profitability Score
ExcellentGLHRL.BO achieves industry-leading margins.
Key Financial Metrics
Is GLHRL.BO Expensive or Cheap?
P/E Ratio
GLHRL.BO trades at 86.37 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, GLHRL.BO's PEG of 0.80 indicates potential undervaluation.
Price to Book
The market values Global Longlife Hospital and R at 0.67 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 44.61 times EBITDA. This signals the market has high growth expectations.
How Well Does GLHRL.BO Make Money?
Net Profit Margin
For every $100 in sales, Global Longlife Hospital and R keeps $34.42 as profit after all expenses.
Operating Margin
Core operations generate -8.04 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $0.76 in profit for every $100 of shareholder equity.
ROA
Global Longlife Hospital and R generates $0.78 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Global Longlife Hospital and R generates strong operating cash flow of $123.25M, reflecting robust business health.
Free Cash Flow
Global Longlife Hospital and R generates strong free cash flow of $122.53M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $11.67 in free cash annually.
FCF Yield
GLHRL.BO converts 71.35% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
86.37
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.80
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.67
vs 25 benchmark
P/S Ratio
Price to sales ratio
29.74
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1616.15
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.008
vs 25 benchmark
ROA
Return on assets percentage
0.008
vs 25 benchmark
ROCE
Return on capital employed
-0.18
vs 25 benchmark
How GLHRL.BO Stacks Against Its Sector Peers
| Metric | GLHRL.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 86.37 | 29.45 | Worse (Expensive) |
| ROE | 0.76% | 779.00% | Weak |
| Net Margin | 34.42% | -24936.00% (disorted) | Strong |
| Debt/Equity | 0.00 | 0.26 | Strong (Low Leverage) |
| Current Ratio | 1616.15 | 4.65 | Strong Liquidity |
| ROA | 0.78% | -19344.00% (disorted) | Weak |
GLHRL.BO outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Global Longlife Hospital and R's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation